Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as an intravenous solution for hospital use. It treats severe bacterial infections such as intra‑abdominal infections, urinary tract infections, pneumonia, meningitis, and sepsis in adult patients.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide with rigorous quality assurance and regulatory compliance.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections affecting various organ systems. - Complicated intra‑abdominal infections: provides bacterial eradication and clinical cure in patients with intra‑abdominal sepsis. - Complicated urinary tract infections: achieves resolution of infection and prevents recurrence in resistant uropathogens. - Nosocomial pneumonia: improves survival and clears pulmonary infection caused by multidrug‑resistant organisms. - Meningitis: penetrates the cerebrospinal fluid to eradicate causative bacteria. - Severe sepsis and septic shock: rapidly reduces bacterial load, supporting hemodynamic stabilization.

Adverse reactions to Meropenem may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Diarrhea: may be watery and self‑limiting. - Headache: occasional transient headache. - Rash: mild erythematous skin eruption. - Elevated liver enzymes: transient increase in hepatic transaminases. - Infusion site phlebitis: irritation at the intravenous site.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: risk increased in patients with CNS disorders or high doses. - Clostridioides difficile‑associated diarrhea: severe colitis requiring treatment. - Severe neutropenia: marked reduction in white blood cells. - Renal impairment: acute kidney injury in susceptible individuals.

Use of Meropenem requires careful assessment of patient factors and proper handling. - Renal function: adjust dose in patients with impaired renal clearance. - Hypersensitivity: avoid in individuals with known carbapenem or β‑lactam allergy. - Seizure risk: monitor closely in patients with pre‑existing CNS disorders or high‑dose therapy. - Pregnancy and lactation: prescribe only when benefit outweighs potential risk. - Antibiotic stewardship: limit use to confirmed bacterial infections to reduce resistance. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Valproic acid: may reduce serum levels, increasing seizure risk. - Probenecid: can raise meropenem concentrations, heightening toxicity. - Nephrotoxic agents (e.g., aminoglycosides): additive renal toxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: may affect renal clearance of meropenem. - Warfarin: monitor INR as meropenem may alter anticoagulant effect. - Oral contraceptives: possible reduced efficacy; advise backup contraception.